Yaz and Yasmin both contain forms of the hormones estrogen and progestin. This dual combination of hormones distinguishes Yaz and Yasmin from other birth control meds, which only contain progestin. Yaz and Yasmin are further distinguished by their incorporation of a synthetic form of progestin not used in other birth control pills. Drospirenone, the synthetic progestin used in Yaz and Yazmin, is linked to an increased risk of dangerous blood clot injuries.

Once a blood clot from Yaz and Yasmin use forms, risks of serious and sometimes fatal complications also increase, including:

  • pulmonary embolisms
  • strokes, and
  • deep vein thrombosis (DVT)

The serious risks of blood clots and their complications from Yaz and Yasmin have prompted authorities to issue warnings about links between blood clots and use of Yaz and Yasmin. These authorities include:

  • European Medicines Agency
  • U.S. FDA
  • New England Journal of Medicine
  • British Medical Journal

If you have suffered the injuries listed above after using Yaz or Yasmin, you may be entitled to substantial compensation from Bayer.

Yaz/Yasmin Adverse Reports

Deep Vein Thrombosis

  • 9,081

Pulmonary Embolism

  • 9,846

General Injury Reports

  • 13,433

General Reports of Pain

  • 15,913

Yaz/Yasmin Uses & Marketing

In 2001, the FDA approved Yasmin for both contraception (birth control) and the treatment of a severe premenstrual condition, Premenstrual Dysphoric Disorder, or PDD. Bayer also marketed both Yaz and Yasmin for control of moderate acne. The marketing of Yaz and Yasmin for the treatment of PDD (severe PMS) and acne was followed by their position as the country’s top-selling birth control drugs in 2008 and 2009.

Safety regulators engaged in closer scrutiny of Yaz and Yasmin after independent studies of a million women showed a greater risk of dangerous blood clots from Yaz and Yasmin than from other birth control medications. Although Bayer denied any wrongdoing, the drug maker received reprimands for advertising that misrepresented the acne and PMS controlling effects of these drugs.

Feldman & Pinto no longer handles Yaz and Yasmin cases.
Please do not contact us about Yaz or Yasmin. Thank you.